Collegium Pharmaceutical (COLL) EBIT (2014 - 2026)
Collegium Pharmaceutical (COLL) reported EBIT of $3.7 million for Q2 2026, down 89.5% from $35.11 million a year earlier and down 88.0% from the prior quarter.
Collegium Pharmaceutical (COLL) EBIT (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Collegium Pharmaceutical's EBIT came in at $157.44 million, up 21.3% year-over-year; for FY2025, it came in at $179.64 million, up 5.7% from FY2024.
- EBIT has increased for four consecutive years, with a five-year compound annual growth rate of 26.1% (FY2020 to FY2025).
- By year, EBIT came in at $169.9 million in FY2024 (+1.8%), $166.96 million in FY2023 (+401.1%), $33.32 million in FY2022 (+89.0%) and $17.63 million in FY2021 (-68.7%).
- The Q2 2026 figure ranks as the lowest quarterly EBIT since Q1 2022.
- Year over year, EBIT gained in three of the last eight quarters, with an average decline of 6.6%.
- The high point for year-over-year EBIT in five years was Q4 2023 (growth of 424.7%); the low point was Q2 2026 (a decline of 89.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $30.9 million (Q1 2026), $60.76 million (Q4 2025) and $62.09 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Collegium Pharmaceutical | 722.44 Mn | -501.32 Mn | 110.29 Mn | 3.70 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 30.90 Mn |
| Dec 31, 2025 | 60.76 Mn |
| Sep 30, 2025 | 62.09 Mn |
| Jun 30, 2025 | 35.11 Mn |
| Mar 31, 2025 | 21.69 Mn |
| Dec 31, 2024 | 38.11 Mn |
| Sep 30, 2024 | 34.84 Mn |
| Jun 30, 2024 | 47.47 Mn |
| Mar 31, 2024 | 49.47 Mn |
| Dec 31, 2023 | 61.69 Mn |
| Sep 30, 2023 | 45.01 Mn |
| Jun 30, 2023 | 35.63 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 11.76 Mn |
| Sep 30, 2022 | 20.47 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Mar 31, 2022 | -10.02 Mn |
| Dec 31, 2021 | -34.12 Mn |
| Sep 30, 2021 | 14.15 Mn |
Collegium Pharmaceutical EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=COLL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();